These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 31325427

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Renoprotective mechanisms of pirfenidone in hypertension-induced renal injury: through anti-fibrotic and anti-oxidative stress pathways.
    Ji X, Naito Y, Weng H, Ma X, Endo K, Kito N, Yanagawa N, Yu Y, Li J, Iwai N.
    Biomed Res; 2013; 34(6):309-19. PubMed ID: 24389407
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protective function of pirfenidone and everolimus on the development of chronic allograft rejection after experimental lung transplantation.
    von Suesskind-Schwendi M, Heigel E, Pfaehler S, Haneya A, Schmid C, Hirt SW, Lehle K.
    Histol Histopathol; 2016 Jul; 31(7):793-805. PubMed ID: 26707547
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney.
    Shimizu T, Kuroda T, Hata S, Fukagawa M, Margolin SB, Kurokawa K.
    Kidney Int; 1998 Jul; 54(1):99-109. PubMed ID: 9648068
    [Abstract] [Full Text] [Related]

  • 9. Establishment of Rat Model of Insulin Resistance Exposed to Chronic Renal Allograft Dysfunction.
    Tang J, Cai D, Jin X, Zhang Y, Qian X, Shen R, Hu B, Jin L, Chen D.
    Transplant Proc; 2021 Jul; 53(1):486-490. PubMed ID: 32768286
    [Abstract] [Full Text] [Related]

  • 10. Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats.
    Chen JF, Liu H, Ni HF, Lv LL, Zhang MH, Zhang AH, Tang RN, Chen PS, Liu BC.
    PLoS One; 2013 Jul; 8(12):e83593. PubMed ID: 24349535
    [Abstract] [Full Text] [Related]

  • 11. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z, Liu X, Wang B, Nie Y, Wen J, Wang Q, Gu C.
    Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
    [Abstract] [Full Text] [Related]

  • 12. Pirfenidone: a novel potential therapeutic agent in the management of chronic allograft rejection.
    Dosanjh A.
    Transplant Proc; 2007 Sep; 39(7):2153-6. PubMed ID: 17889122
    [Abstract] [Full Text] [Related]

  • 13. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
    Zhao XY, Zeng X, Li XM, Wang TL, Wang BE.
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
    [Abstract] [Full Text] [Related]

  • 14. Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model.
    Guan Q, Li S, Gao S, Chen H, Nguan CY, Du C.
    Am J Physiol Renal Physiol; 2013 Jul 15; 305(2):F199-207. PubMed ID: 23552866
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction of chronic renal allograft dysfunction in a rat model with complete and exclusive MHC incompatibility.
    Poehnert D, Broecker V, Mengel M, Nashan B, Koch M.
    Transpl Immunol; 2010 Feb 15; 22(3-4):137-43. PubMed ID: 19815070
    [Abstract] [Full Text] [Related]

  • 18. Pirfenidone is a renal protective drug: Mechanisms, signalling pathways, and preclinical evidence.
    Bai X, Nie P, Lou Y, Zhu Y, Jiang S, Li B, Luo P.
    Eur J Pharmacol; 2021 Nov 15; 911():174503. PubMed ID: 34547247
    [Abstract] [Full Text] [Related]

  • 19. Chronic allograft nephropathy in rats is improved by the intervention of rhein.
    Su J, Yin LP, Zhang X, Li BB, Liu L, Li H.
    Transplant Proc; 2013 Nov 15; 45(6):2546-52. PubMed ID: 23953579
    [Abstract] [Full Text] [Related]

  • 20. Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway.
    Liu H, Drew P, Gaugler AC, Cheng Y, Visner GA.
    Am J Transplant; 2005 Jun 15; 5(6):1256-63. PubMed ID: 15888029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.